Associate Professor of Maternal Fetal Medicine
University of North Carolina at Chapel Hill
William Goodnight, MD, MSCR is an Associate Professor in the Division of Maternal Fetal Medicine at the University of North Carolina School of Medicine, in Chapel Hill, North Carolina. Dr Goodnight completed medical school at UNC Chapel Hill, OB/GYN residency at the Virginia Commonwealth University, worked in private practive OB/GYN before returning to MFM Fellowship at the Medical University of South Carolina.
Dr Goodnight returned to UNC in 2008 joining MFM the faculty. Current clinical include special interest in obstetric ultrasound, prenatal diagnosis and fetal treatment, and management of multiple pregnancies. Dr Goodnight serves as the Medical Director for the UNCH Fetal Care Program, providing full scope fetoscopic, ultrasound guided, and open in-utero fetal treatment for congenital anomalies and multifetal complications, and is co-director of the UNC Placenta Accreta program.
Dr Goodnight's current areas of research include fetal interventions, OB imaging, and multiple gestation. Dr Goodnight is the PI for the North American Fetal Therapy Network Monochorionic Twin Registry, an international registry of complicated twin pregnancies, the UNC site PI for the GOOD study, and MMC consortium registry. Dr Goodnight is currently the UNC Site PI for the J&J Azalea study, an international RCT for prevention of HDFN in alloimmunized pregnancies.
Dr Goodnight is active in education and developed the ongoing SMFM Fellow Lecture Series in 2009. Dr Goodnight was part of the founding faculty for the SMFM/Banner Critical Care in Obstetrics online program. Dr Goodnight leads simulation programs for needle guided fetal interventions and MFM fellow OB imaging lecture series.
Dr Goodnight has served on the Board of Directors and as Treasurer for the North American Fetal Therapy Network and served on the Board of Directors for the Society for Maternal Fetal Medicine.
Outside of work Dr Goodnight is a active fly-fisher, whitewater kayaker, and ultra-runner.